Financial Data and Key Metrics Changes - Second quarter revenue grew 7.2% year over year in constant currency to $5.2 billion, marking the fourth consecutive quarter of year-over-year organic growth [6][26] - Adjusted operating margin improved by 40 basis points year over year to 15.6%, on track to achieve a margin expansion goal of 20 to 40 basis points for 2025 [8][34] - Bookings grew 18% year over year, with trailing twelve months growth of 6%, and the total contract value (TCV) of large deals more than doubled year over year [7][34] Business Line Data and Key Metrics Changes - Financial Services grew 6% year over year, driven by digital engineering and legacy modernization initiatives [27] - Health Sciences grew 5% year over year, supported by organic growth across payers, providers, and life sciences customers [28] - Communication, Media, and Technology returned to organic growth, led by the technology sector, with robust demand for cost reduction and capital reallocation [31] Market Data and Key Metrics Changes - North America led revenue growth with 8%, driven by financial services and health sciences [32] - Europe grew 4%, supported by life sciences and financial services clients [33] - The Rest of the World increased by about 6%, with growth driven by financial services and health sciences [33] Company Strategy and Development Direction - The company is focusing on AI-led opportunities and disciplined execution to build a resilient and durable business [4][20] - The three-vector AI strategy includes productivity, industrializing AI, and agentifying the enterprise, with a strong emphasis on innovation-led projects [5][11] - The company is expanding its talent investments in emerging technology hubs and enhancing its AI capabilities through strategic partnerships [12][18] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the demand environment, noting strong large deal momentum and a growing number of new spend cycles [24][40] - The company expects revenue growth of 4% to 6% in constant currency for 2025, reflecting improved confidence in the second half of the year [38] - Management highlighted the importance of AI in driving productivity and innovation, positioning the company for future growth [20][21] Other Important Information - The company plans to return $2 billion to shareholders in 2025, with $1.4 billion allocated for share repurchases [42] - A one-time non-cash tax expense of approximately $400 million is expected in Q3 due to changes in US tax laws [36] Q&A Session Summary Question: Clarification on bookings and pipeline outlook - Management confirmed a balanced mix of renewals and new business, with a healthy outlook for bookings in the second half of the year [46][50] Question: Gross margin outlook - Management indicated that gross margin will be shaped by resource utilization and investments in large deals, with stable margins expected [51][53] Question: Pricing and incorporation of AI agents into deals - Management discussed the potential for outcome-based pricing and the differentiation created by their AI capabilities [58][60] Question: Healthcare segment headwinds and offsets - Management noted that while there are headwinds in healthcare, there are also opportunities for productivity-led growth [90][91] Question: Convergence of IT services and BPM - Management highlighted the unique opportunity presented by the convergence of operations and technology, emphasizing the role of AI in transforming client operations [92][93]

Financial Data and Key Metrics Changes - Second quarter revenue grew 7.2% year over year in constant currency to $5.2 billion, marking the fourth consecutive quarter of year-over-year organic growth [6][26] - Adjusted operating margin improved by 40 basis points year over year to 15.6%, on track to achieve a margin expansion goal of 20 to 40 basis points for 2025 [7][35] - Bookings grew 18% year over year, translating to trailing twelve months growth of 6% [6][34] - Free cash flow for the second quarter was $331 million, compared to $183 million a year ago [36] Business Line Data and Key Metrics Changes - Financial Services grew 6% year over year, driven by digital engineering and legacy modernization [27] - Health Sciences grew 5% year over year, supported by organic growth across payers, providers, and life sciences customers [28] - Communication, Media, and Technology returned to organic growth, led by the technology sector [31] Market Data and Key Metrics Changes - North America led revenue growth with 8%, driven by financial services and health sciences [32] - Europe grew 4%, supported by life sciences and financial services clients [33] - The Rest of the World increased by about 6%, driven by financial services and health sciences [33] Company Strategy and Development Direction - The company is focusing on AI-led opportunities and disciplined execution to build a resilient and durable business [4] - The strategy includes a three-vector approach: enabling hyper productivity, industrializing AI, and identifying the enterprise [81] - The company is expanding its talent investments in emerging technology hubs and enhancing its AI capabilities [12][13] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the ability to drive large deal momentum and win new spend cycles in AI opportunities [23] - The demand environment remains dynamic, but the company is encouraged by its performance and pipeline [23][40] - The company expects revenue growth of 4% to 6% in constant currency for the full year 2025 [39] Other Important Information - The company plans to return $2 billion to shareholders in 2025, an increase from previous guidance [42] - A one-time non-cash tax expense of approximately $400 million is expected in Q3 due to changes in US tax laws [37] Q&A Session Summary Question: Clarification on bookings and pipeline outlook - Management confirmed a balanced mix of renewals and new business, with a healthy pipeline for the second half of the year [49][53] Question: Gross margin outlook - Management indicated that gross margin will be shaped by resource utilization and investments in large deals [54][57] Question: Pricing and business opportunities related to AI agents - Management discussed the potential for outcome-based pricing and the differentiation created by their AI capabilities [62][66] Question: Capital allocation and M&A pipeline - Management provided an update on capital allocation plans, indicating a decent pipeline for M&A in the second half of the year [69] Question: Healthcare segment headwinds and offsets - Management noted that their exposure to Medicaid and Medicare is limited, with a focus on productivity-led opportunities in healthcare [95] Question: Convergence of IT services and BPM - Management highlighted the unique opportunity presented by the convergence of operations, data, and AI [96] Question: Headcount increase and outlook for the second half - Management acknowledged the increase in headcount and its implications for resource management moving forward [101]